Xie, Kai
Gao, Liugang
Zhang, Yutao
Zhang, Heng
Sun, Jiawei
Lin, Tao
Sui, Jianfeng
Ni, Xinye
Funding for this research was provided by:
the National Natural Science Foundation of China (62371243)
Changzhou Social Development Program (CE20235063)
Jiangsu Provincial Key Research and Development Program Social Development Project (BE2022720)
General Program of Jiangsu Provincial Health Commission (M2020006)
Jiangsu Provincial Medical Key Discipline Cultivation Unit of Oncology Therapeutics (JSDW202237)
the National Natural Science Foundation of Jiangsu (BK20231190)
Article History
Received: 17 June 2024
Accepted: 25 July 2024
First Online: 6 August 2024
Declarations
:
: The experimental protocol was established, according to the ethical guidelines of the Helsinki Declaration and was approved by the ethics committee of the Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University (approval number: [2020]KY154-01) and waived the requirement for written informed consent from patients.
: Not applicable.
: The authors declare no competing interests.